AAAAAA

   
Results: 1-12 |
Results: 12
Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha(1a)-adrenergic receptor antagonists
Authors: Lagu, B Tian, D Chiu, G Nagarathnam, D Fang, J Shen, QR Forray, C Ransom, RW Chang, RSL Vyas, KP Zhang, KY Gluchowski, C
Citation: B. Lagu et al., Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha(1a)-adrenergic receptor antagonists, BIOORG MED, 10(2), 2000, pp. 175-178
Phenylacetamides as selective alpha-1A adrenergic receptor antagonists
Authors: Patane, MA DiPardo, RM Newton, RC Price, RP Broten, TP Chang, RSL Ransom, RW Di Salvo, J Nagarathnam, D Forray, C Gluchowski, C Bock, MG
Citation: Ma. Patane et al., Phenylacetamides as selective alpha-1A adrenergic receptor antagonists, BIOORG MED, 10(15), 2000, pp. 1621-1624
De novo design of a novel oxazolidinone analogue as a potent and selectivealpha(1A) adrenergic receptor antagonist with high oral bioavailability
Authors: Lagu, B Tian, D Jeon, Y Li, C Wetzel, JM Nagarathnam, D Shen, QR Forray, C Chang, RSL Broten, TP Ransom, RW Chan, TB O'Malley, SS Schorn, TW Rodrigues, AD Kassahun, K Pettibone, DJ Freidinger, R Gluchowski, C
Citation: B. Lagu et al., De novo design of a novel oxazolidinone analogue as a potent and selectivealpha(1A) adrenergic receptor antagonist with high oral bioavailability, J MED CHEM, 43(15), 2000, pp. 2775-2778
In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia
Authors: Barrow, JC Nantermet, PG Selnick, HG Glass, KL Rittle, KE Gilbert, KF Steele, TG Homnick, CF Freidinger, RM Ransom, RW Kling, P Reiss, D Broten, TP Schorn, TW Chang, RSL O'Malley, SS Olah, TV Ellis, JD Barrish, A Kassahun, K Leppert, P Nagarathnam, D Forray, C
Citation: Jc. Barrow et al., In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia, J MED CHEM, 43(14), 2000, pp. 2703-2718
In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha(1A)-adrenoceptor antagonist
Authors: Chang, RSL Chen, TB O'Malley, SS Pettibone, DJ DiSalvo, J Francis, B Bock, MG Freidinger, R Nagarathnam, D Miao, SW Shen, QR Lagu, B Dhar, TGM Tyagarajan, S Marzabadi, MR Wong, WC Gluchowski, C Forray, C
Citation: Rsl. Chang et al., In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha(1A)-adrenoceptor antagonist, EUR J PHARM, 409(3), 2000, pp. 301-312
Design and synthesis of novel dihydropyridine alpha-1A antagonists
Authors: Marzabadi, MR Hong, XF Nagarathnam, D Miao, SW Chiu, G Wong, WC Wetzel, JM Fang, J Forray, C Chen, TB O'Malley, SS Chang, RSL Gluchowski, C
Citation: Mr. Marzabadi et al., Design and synthesis of novel dihydropyridine alpha-1A antagonists, BIOORG MED, 9(19), 1999, pp. 2843-2848
Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones
Authors: Nagarathnam, D Miao, SW Lagu, B Chiu, G Fang, J Dhar, TGM Zhang, J Tyagarajan, S Marzabadi, MR Zhang, FQ Wong, WC Sun, WY Tian, D Wetzel, JM Forray, C Chang, RSL Broten, TP Ransom, RW Schorn, TW Chen, TB O'Malley, S Kling, P Schneck, K Bendesky, R Harrell, CM Vyas, KP Gluchowski, C
Citation: D. Nagarathnam et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones, J MED CHEM, 42(23), 1999, pp. 4764-4777
Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification oflinker and 4-methoxycarbonyl-4-phenylpiperidine moiety
Authors: Dhar, TGM Nagarathnam, D Marzabadi, MR Lagu, B Wong, WC Chiu, G Tyagarajan, S Miao, SW Zhang, FQ Sun, WY Tian, D Shen, QR Zhang, J Wetzel, JM Forray, C Chang, RSL Broten, TP Schorn, TW Chen, TB O'Malley, S Ransom, R Schneck, K Bendesky, R Harrell, CM Vyas, KP Zhang, KY Gilbert, J Pettibone, DJ Patane, MA Bock, MG Freidinger, RM Gluchowski, C
Citation: Tgm. Dhar et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification oflinker and 4-methoxycarbonyl-4-phenylpiperidine moiety, J MED CHEM, 42(23), 1999, pp. 4778-4793
Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains
Authors: Lagu, B Tian, D Nagarathnam, D Marzabadi, MR Wong, WC Miao, SW Zhang, FQ Sun, WY Chiu, G Fang, J Forray, C Chang, RSL Ransom, RW Chen, TB O'Malley, S Zhang, KY Vyas, KP Gluchowski, C
Citation: B. Lagu et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains, J MED CHEM, 42(23), 1999, pp. 4794-4803
Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series
Authors: Wong, WC Sun, WY Lagu, B Tian, D Marzabadi, MR Zhang, FQ Nagarathnam, D Miao, SW Wetzel, JM Peng, J Forray, C Chang, RSL Chen, TB Ransom, R O'Malley, S Broten, TP Kling, P Vyas, KP Zhang, KY Gluchowski, C
Citation: Wc. Wong et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series, J MED CHEM, 42(23), 1999, pp. 4804-4813
GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2
Authors: Jones, KA Borowsky, B Tamm, JA Craig, DA Durkin, MM Dai, M Yao, WJ Johnson, M Gunwaldsen, C Huang, LY Tang, C Shen, QR Salon, JA Morse, K Laz, T Smith, KE Nagarathnam, D Noble, SA Branchek, TA Gerald, C
Citation: Ka. Jones et al., GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2, NATURE, 396(6712), 1998, pp. 674-679
Design and synthesis of novel alpha(1a) adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia
Authors: Nagarathnam, D Wetzel, JM Miao, SW Marzabadi, MR Chiu, G Wong, WC Hong, XF Fang, J Forray, C Branchek, TA Heydorn, WE Chang, RSL Broten, T Schorn, TW Gluchowski, C
Citation: D. Nagarathnam et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia, J MED CHEM, 41(26), 1998, pp. 5320-5333
Risultati: 1-12 |